Last reviewed · How we verify

NCT06954779

Arginine Plaque Metabolism Pilot Clinical Study

Completed Phase 3 Last updated 2 May 2025
What this trial tests

Phase 3 trial testing Colgate Cavity Protection in Plaque, Dental in 20 participants. Completed in 20 September 2024.

Timeline
24 July 2024
Primary endpoint
20 September 2024
20 September 2024

Quick facts

Lead sponsorColgate Palmolive
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingtriple
Primary purposetreatment
Enrollment20
Start date24 July 2024
Primary completion20 September 2024
Estimated completion20 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Colgate Palmolive — full company profile →

Who can join

Adults 18 to 70, any sex, with Plaque, Dental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Colgate Cavity Protection

Trials testing the same drug.

Other recruiting trials for Plaque, Dental

Currently open trials in the same condition.

Other Colgate Palmolive trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06954779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing